Back to search
FDAFDA · Food and drugs·Recall number D-0230-2025

Phenylephrine HCl Injection, USP 100 mg/10 mL (10 mg/mL) vials, Rx only, Pharmacy Bulk Package (supplied as a single unit), Dist. by: Provepharm, Inc., Collegeville, PA 19426

Published February 26, 2025 · Recall initiated: January 21, 2025

Summary

FDA records drug Class I recall D-0230-2025, published February 26, 2025 and initiated January 21, 2025. Recalling firm: Provepharm Inc.; Status: Ongoing; Reported quantity: 24640 vials; Lot: Lot# 24020027, Exp Date: 12/31/2025. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Provepharm Inc.
Distributor
Nationwide in the U.S.
Lot
Lot# 24020027, Exp Date: 12/31/2025
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Phenylephrine HCl Injection, USP 100 mg/10 mL (10 mg/mL) vials, Rx only, Pharmacy Bulk Package (supplied as a single unit), Dist. by: Provepharm, Inc., Collegeville, PA 19426 recalled?

Yes. FDA published recall D-0230-2025 on February 26, 2025. Reported hazard: Presence of Particulate Matter.

What should I do if I have this product?

Voluntary: Firm initiated · Letter